We are thrilled to invite you to the biggest pharmaceutical event of the year – CPHI 2023 in Barcelona! 🌍

QUINTA-ANALYTICA as a part of Conscio Group, along with our network of companies:, Gen-Plus GmbH & Co. KG, EL Labs, LVA GmbH and strategic partner DiHeSys – Digital Health Systems GmbH, are looking forward to meeting our current partners and friends, and to establish new collaborations and opportunities.

Come meet with us and explore how our collective expertise can drive innovation in #pharmaceuticalresearch #PharmaInnovation, #Bioanalysis, #ClinicalTrials and #manufacturingprocces.

📅 Date: 24th-26th October
📍 Booth: 4H30

🤝 If you’re interested in meeting with us, mention us in the comments, send us a private message or contact us at info@consciogroup.com or sales@quinta.cz, and we’ll schedule a meeting.

Additional News

  • 16 April 2026

    Expanding Beyond FDA & EMA: Strengthening Our Global Regulatory Footprint with GCC

    Quinta-Analytica has successfully completed a full on-site GCP inspection within the GCC framework, further strengthening its international regulatory footprint and clinical research credibility.

  • 25 March 2026

    ADC Webinar: DAR, Bioanalysis and Intact MS in Next-Generation ADC Development

    On behalf of Conscio Group, registration is now open for our free expert-led webinar on DAR characterization, bioanalytical strategy and mass spectrometry insight in ADC development.

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

ALL POSTS